BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7368290)

  • 1. Biologic effects of the altered MHS profile on the K36 tumor, a spontaneous leukemia of AKR.
    Festenstein H; Schmidt W; Testorelli C; Marelli O; Simpson S
    Transplant Proc; 1980 Mar; 12(1):25-8. PubMed ID: 7368290
    [No Abstract]   [Full Text] [Related]  

  • 2. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia.
    Schmidt W; Festenstein H; Atfield G
    Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291
    [No Abstract]   [Full Text] [Related]  

  • 3. Further molecular and functional evidence for the expression of H-2 allodeterminants on the AKR leukemia, K36.
    Festenstein H; Alonzo AD; Ferluga J; Ma BL; Santamaria M; Marelli O; Schmidt W; Flavell RA
    Transplant Proc; 1983 Dec; 15(4):2107-10. PubMed ID: 6200978
    [No Abstract]   [Full Text] [Related]  

  • 4. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 5. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 7. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR.
    Schmidt W; Festenstein H
    J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic control of murine leukemias induced by Moloney virus].
    Debré P; Gisselbrecht S; Boyer B; Lévy JP
    Bull Cancer; 1982; 69(2):178-87. PubMed ID: 6812667
    [No Abstract]   [Full Text] [Related]  

  • 9. Variation in MHC antigenic profiles of tumor cells and its biological effects.
    Festenstein H; Schmidt W
    Immunol Rev; 1981; 60():85-127. PubMed ID: 6171505
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteration of skin in Gross leukemia. 3. Quantitation of the role of tumor cells.
    Mariani T; Maruyama Y; Good RA
    J Natl Cancer Inst; 1972 Feb; 48(2):363-6. PubMed ID: 4568966
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular analysis of the cytolytic T-lymphocyte response elicited by retrovirus-induced tumours in mice.
    Plata F; Langlade-Demoyen P; Abastado JP; Berbar T; Kourilsky P
    Ann Inst Pasteur Immunol; 1986; 137D(3):409-12. PubMed ID: 3493789
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoreactive cells in cancer-active immunotherapy: their cytotoxic potential and genetic restriction.
    Olsson L; Kiger N; Mathe G
    Transplant Proc; 1980 Mar; 12(1):167-71. PubMed ID: 7368287
    [No Abstract]   [Full Text] [Related]  

  • 13. Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):89-96. PubMed ID: 4880891
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential regulation of H-2 antigen expression in tumors and its biologic consequences.
    Schmidt W; Alonso A; Leben L; Festenstein H
    Transplant Proc; 1981 Dec; 13(4):1814-8. PubMed ID: 7330969
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic studies on Graffi-virus-infected spontaenous Gross leukemia of AKR mice.
    Micheel B; Pasternak G
    Int J Cancer; 1968 Sep; 3(5):603-13. PubMed ID: 4302083
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF; Cook WJ; Green WR
    Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of immunological differences between Graffi- and Gross-virus induced mouse leukemias in vivo and in vitro].
    Pasternak G; Hölzer B
    Neoplasma; 1965; 12(4):339-55. PubMed ID: 4285320
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of a rapidly growing AKR lymphoblastic cell line maintaining Gross antigens and viral replication.
    Woods WA; Wivel NA; Massicot JG; Chirigos MA
    Cancer Res; 1970 Aug; 30(8):2147-55. PubMed ID: 4918189
    [No Abstract]   [Full Text] [Related]  

  • 19. Wild-type Gross leukemia virus. 3. Serological tests as indicators of leukemia risk.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):103-10. PubMed ID: 4873848
    [No Abstract]   [Full Text] [Related]  

  • 20. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T; Maruyama Y
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.